ITULATEK
LIVE

Serial Number

87886775

Owner

ALK-Abelló A/S

Attorney

Monica Riva Talley

Filing Date

Apr 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ITULATEK Trademark

Serial Number: 87886775 • Registration: 6115768

ITULATEK is a trademark filed by ALK-Abelló A/S on April 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ALK-Abelló A/S (37 trademarks)

Bøge Allé 6-8
DK-2970 Hørsholm , DK

Entity Type: 99

Trademark Details

Filing Date

April 20, 2018

Registration Date

August 4, 2020

Published for Opposition

May 19, 2020

Goods & Services

Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, diagnostic reagents and diagnostic testing materials being medical diagnostic test strips, diagnostic test patch for application to the skin for determining allergies, medical diagnostic test media in the form of test strips, all for medical use in diagnosing, preventing and treating allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases

Medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; providing patient support, namely, providing medical and health care information, all relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums and electronically or digitally through the Internet; providing health and medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet

Medical and pharmacological research services in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; conducting clinical trials for others

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 4, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 10, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 25, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 27, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 27, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 27, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 27, 2019 RCCK
ASSIGNED TO LIE
Sep 26, 2019 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2019 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2018 NWOS
NEW APPLICATION ENTERED
Apr 24, 2018 NWAP